Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
Keywords: دامنه گیرنده گیرنده; MERS-CoV; Receptor-binding domain; Humanized monoclonal antibody; Protection; Treatment; Lethal infection; CPE; cytopathic effect; EC50; half-maximal effective concentration; hDPP4; human dipeptidyl peptidase 4; MERS-CoV; Middle East respiratory syndrome